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ABSTRACT  
Aim: The aim of the present study was to investigate the association between hypothyroidism and non-alcoholic fatty liver disease (NAFLD).  
Methods: In a prospective observational study, the hypothyroidism patients were evaluated for NAFLD using ultrasonography. The 
participant’s characteristics such as age, gender, thyroid profile, history of diabetes, hypertension, ischemic heart disease  (IHD) were recorded 
using a data gathering form. 
Results: A total of 51 participants were included in this study. From 51 participants, 47 (92.18%) individuals were females whereas 4 (7.82%) 
individuals were males. Out of 51 participants 27 individuals had NAFLD. There was statistically significant difference in FT 4 levels with the 
participants with NAFLD. 
Conclusion: Results from this study suggested that low FT4 concentration is associated with increased risk of NAFLD.  
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The thyroid gland is a source of fundamentally two different 
types of hormones. The thyroid follicle produces the two 
iodothyronine hormone, thyroxine (T4) and 3,5,3’-
triidothyronine (T3). These hormones are essential for the 
growth of the cells, development of the cells and play an 
important role in energy metabolism. The thyroid also 
contains a para follicular cell (C-cells) that produces 
calcitonin. Serum concentration of thyroid hormones are 
precisely regulated by the pituitary hormone “Thyrotropin” 
(thyroid stimulating hormone, TSH) [1]. Thyroid hormones 
affect the role of almost every organ system. In a child, 
thyroid hormone is critical for normal growth and 
development. The major role of thyroid hormone in an adult 
is to maintain metabolic stability. Thyroid hormones play an 
important role in thermogenesis and influence all major 
metabolic pathways such as protein, carbohydrate and lipid 
metabolism [2]. Hypothyroidism or underactive thyroid is 
defined as the clinical and biochemical syndrome resulting 
from decreased thyroid hormone production [3]. 
Hypothyroidism can cause a number of symptoms, like 
weight gain, weakness, joints pain, constipation, depression, 
and hair loss. Occasionally there may be swelling of the front 
part of the neck due to goiter [4]. Untreated hypothyroidism 
during pregnancy can lead to delays in growth and 
intellectual development in the baby or congenital iodine 
deficiency syndrome [5]. Subclinical hypothyroidism is a 
milder form of hypothyroidism characterized by an elevated 
serum TSH level, but with a normal serum free thyroxine 
level [6,7]. This milder form of hypothyroidism is most 
commonly caused by Hashimoto's thyroiditis [8]. In adults it 
is diagnosed when TSH levels are greater than 5mIU/L and 
less than 10mIU/L [9]. The presentation of subclinical 
hypothyroidism is variable and classic signs and symptoms 
of hypothyroidism may not be observed [6]. Non-alcoholic 
fatty liver disease (NAFLD) is the most common chronic liver 
condition all over the world [10-13]. NAFLD develops in the 
absence of excessive alcohol consumption and ranging from 
the simple steatosis to NASH, even to fibrosis and cirrhosis 
that can possibly progress to liver failure or hepatocellular 
carcinoma [14,15]. Moreover, accumulating evidence has 
shown that NAFLD, either independently or in combination 
with other metabolic risk factors, is associated with extra 
hepatic complications such as cardiovascular disease, T2DM, 
CKD, malignancy, and all-cause mortality [16-19]. Despite 
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improved understanding and treatment of its risk factors 
(e.g., diabetes and dyslipidemia), prevalence of NAFLD has 
rapidly increased [20]. NAFLD has no definitive biochemical 
markers or peculiar clinical signs. A simple and effective 
screening approach for NAFLD should include inquiry into 
other common causes of fatty liver (alcohol, drugs, hepatitis 
C virus–related chronic hepatitis, hemochromatosis), an 
ultrasound scan of the liver and assessment of serum 
transaminase levels. All over the world, hypothyroidism is 
one of the most common disease. Thyroid hormones play a 
fundamental role in the lipid metabolism. Results of some of 
the reviewed studies showed that hypothyroidism play an 
important role in the development of NAFLD. This may lead 
us to find out the association between hypothyroidism and 
NAFLD. It is remains unclear that whether the 
hypothyroidism is the risk factor for the progression of 
NAFLD, or if it, then to what extent hypothyroidism affects 
the NAFLD. Studies confined to euthyroid subjects have been 
inconsistent as well, reporting that free T4 (FT3) alone (12), 
TSH alone (13), both (5), or neither of them (14) are linked 
with NAFLD. These discrepancies are mainly due to small 
sizes and cross-sectional design of previous studies. 
Hypothyroidism is a modifiable risk factor and can easily be 
treated with thyroid replacement therapy. In this study, we 
will rule out that whether the hypothyroidism is a risk factor 
for the progression of non-alcoholic fatty liver disease or 
not. 
MATERIALS AND METHODS:  
This prospective observational study was conducted at Shri 
Mahant Indiresh Hospital, Patel Nagar, Dehradun. From 
February 2019 to July 2019, patients coming to the medicine 
OPD department with the complaints of thyroid dysfunction 
(hypothyroidism) were enrolled in this study. The Protocol 
of the study was approved by Institutional Ethics Committee 
and a written informed consent form was obtained from all 
the patients. In this study, all male and female patients with 
hypothyroidism were included. Patients with other 
metabolic syndrome and pediatric groups were excluded. 
Alcoholic patients were also excluded. Initially demographic 
information was collected from all the individuals. 4 clinical 
and biochemical parameters that are FT3, FT4, serum TSH 
and ultrasonography were evaluated and assessed in the 
central laboratory of the Shri Mahant Indiresh Hospital. Data 
was analyzed by Statistical Package for Social Sciences 
(SPSS) version 20. Statistical analysis was performed by 
using Unpaired T test for analysis of change in FT3, FT4, 
serum TSH and ultrasonography. All p value less than 0.05 
were considered as statistically significant. The strength of 
the association between FT3, FT4, TSH and ultrasonography 
were calculated by using Karl Pearson correlation coefficient 
(r).  
RESULTS:  
According to the data collected in the study, among 51 
patients, 4 patients were males and 47 patients were 
females accounting for 92.16% and 7.84% respectively. Out 
of 51 patients, 17 (33%) patients were in the age group of 
41-50 years, 14 (27%) patients were in the age group of 18-
30 years, 13 (26%) patients were in the age group of 31-40 
years, 6 (12%) patients were in the age group of 51-60 and 
only 1 (2%) patient was in the age group of more than 60 
years. 15 patients were from the urban areas, whereas, 36 
patients were from the rural areas. 45 patients were 
complaining of generalized weakness, 42 patients were 
complaining of weight gain, 32 patients were complaining of 
joints pain, 12 patients were complaining of constipation, 16 
patients were complaining of swelling over the body and 10 
patients were complaining of hair loss.  
Out of 51 patients, 27 patients were suffering from NAFLD 
and 24 patients were without NAFLD. Out of 27 patients, 23 
patients were found with grade I fatty liver, 3 patients were 
found with grade II fatty liver and only 1 patient was found 
with grade III fatty liver. 
Association between thyroid dysfunction and NAFLD: T 
test was performed to check the accuracy of the data. Total 6 
parameters were taken in the test and total 51 patients were 
investigated in this procedure. Statics of results are shown in 
the table no 1 and table no 2. 
  








Std. Error Mean 
Age 51 39.24 10.792 1.511 
Gender 51 1.92 .272 .038 
FT3 51 4.7871 1.47901 .20710 
FT4 51 14.7853 5.33802 .74747 
TSH 51 14.2778 31.14473 4.36114 
USG 51 1.63 .692 .097 
 
            Table No 2. Statistics using 2 tailed Student T-test 
 Test Value = 0 
t df Sig. (2-tailed) Mean Difference 
95% Confidence Interval of the Difference 
Lower Upper 
Age 25.964 50 .000 39.235 36.20 42.27 
Gender 50.540 50 .000 1.922 1.85 2.00 
FT3 23.114 50 .000 4.78706 4.3711 5.2030 
FT4 19.780 50 .000 14.78529 13.2840 16.2866 
TSH 3.274 50 .002 14.27784 5.5182 23.0374 
USG 16.803 50 .000 1.627 1.43 1.82 
 
Correlation: To find out the strength of the association of 
FT3, FT4 and TSH with the ultrasonography, Karl Pearson’s 
correlation was studied at the base line. A significant 
association of FT4 with ultrasonography was found. But no 
significant association was found with FT3 and TSH level as 
shown in table no 3. 
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Table No. 3. Correlation between thyroid functions and USG 
 FT3 FT4 TSH USG 
FT3 Pearson Correlation 1 .230 -.291* -.062 
 Sig. (2-tailed)  .105 .038 .668 
 N 51 51 51 51 
FT4 Pearson Correlation .230 1 -.403** .334* 
 Sig. (2-tailed) .105  .003 .017 
 N 51 51 51 51 
TSH Pearson Correlation -.291* -.403** 1 -.083 
 Sig. (2-tailed) .038 .003  .564 
 N 51 51 51 51 
USG Pearson Correlation -.062 .334* -.083 1 
 Sig. (2-tailed) .668 .017 .564  
 N 51 51 51 51 
    *. Correlation is significant at the 0.05 level (2-tailed).  **. Correlation is significant at the 0.01 level (2-tailed). 
DISCUSSION:  
Hypothyroidism is a metabolic disorder in which the thyroid 
gland can’t produce the required amount of thyroid 
hormones (FT3 & FT4) which can be lead to the 
malfunctioning of the metabolism of the human body. This 
metabolic disorder causes decreased absorption of the 
carbohydrate, protein and lipid from the synthesis site that 
is hepatocytic cells. The inability of the lipid utilization 
causes storage of the lipid content in the hepatocytes that 
causes progression of NAFLD. In this study the relation of 
the Hypothyroidism was checked with the NAFLD. The 
patients of Hypothyroidism were investigated and 
diagnosed pathologically for the amount of serum TSH, FT4 
and FT3 hormones in their body. And they were also tested 
for NAFLD by ultrasonography. The results showed that 51 
patients were suffering from Hypothyroidism out of which 
27 patients were also suffering from NAFLD. Results indicate 
that there is an association of NAFLD with the 
Hypothyroidism which may due to the malfunctioning of the 
metabolism caused by hyper production of serum TSH and 
insufficient amount of FT4 and FT3 hormones in the body. 
So it is important to control the level of FT3 and FT4 
hormones in the body to prevent the risk of NAFLD. And in 
the patients  that are suffering from both Hypothyroidism 
and NAFLD, they should be first prioritized for the control of 
Hypothyroidism, that will support the proper function of the 
metabolic reactions leading to good health of the liver and 
reduction in the amount of fat in the hepatocytes. So control 
of Hypothyroidism is necessary for it. Hypothyroidism can 
be easily treated with the help of thyroid replacement 
therapy (LEVOTHYROXINE). There is no effective drug is yet 
discovered for the treatment of NAFLD but liver has 
regeneration ability, so maintaining good level of thyroid 
hormones by thyroid replacement therapy with good diet 
and proper exercise can help in NAFLD.  
CONCLUSION:  
Results from the study suggested that the lower 
concentration of the FT4 in the body have significant role in 
progression of the NAFLD. To treat NAFLD it is required to 
first control hypothyroidism with the significant use of 
Thyroid replacement therapy. It is also suggested that the 
control balanced diet and exercise is required to get rid from 
NAFLD.   
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